ENDOMETRIAL CARCINOMA
Clinical trials for ENDOMETRIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIAL CARCINOMA trials appear
Sign up with your email to follow new studies for ENDOMETRIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blueberry compound joins hormone therapy in fight against uterine cancer
Disease control OngoingThis study tests whether adding pterostilbene (an antioxidant from blueberries) to the hormone drug megestrol acetate works better than megestrol acetate alone in shrinking endometrial cancer or precancerous growths before hysterectomy. About 44 participants will take the drugs f…
Matched conditions: ENDOMETRIAL CARCINOMA
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 17, 2026 01:31 UTC
-
New hope for hard-to-treat endometrial cancer: targeted drug shows promise in early trial
Disease control OngoingThis study tests a drug called sacituzumab govitecan in 50 people with endometrial cancer that has returned or not responded to platinum chemotherapy. The drug works by delivering chemotherapy directly to cancer cells. The main goal is to see how many patients' tumors shrink or d…
Matched conditions: ENDOMETRIAL CARCINOMA
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 08, 2026 13:11 UTC
-
Online support for cancer fear: study withdrawn before it began
Knowledge-focused TerminatedThis study was designed to see if a virtual mental health program could help women with advanced gynecologic or breast cancer manage their fear of the cancer coming back or getting worse. The program would have been compared to standard educational materials. However, the study w…
Matched conditions: ENDOMETRIAL CARCINOMA
Phase: NA • Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated Jun 08, 2026 13:17 UTC